Dai ichi Life Insurance Company Ltd raised its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 4.0% during the 3rd quarter, HoldingsChannel reports. The fund owned 51,913 shares of the conglomerate’s stock after acquiring an additional 2,000 shares during the quarter. Dai ichi Life Insurance Company Ltd’s holdings in Danaher were worth $14,433,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also modified their holdings of the business. Fort Pitt Capital Group LLC raised its position in Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after purchasing an additional 7,421 shares during the period. Good Life Advisors LLC purchased a new position in shares of Danaher during the third quarter valued at approximately $217,000. Oak Thistle LLC purchased a new position in Danaher in the 2nd quarter worth about $363,000. Harvest Portfolios Group Inc. raised its holdings in shares of Danaher by 1.2% in the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after acquiring an additional 2,465 shares in the last quarter. Finally, Diversified Trust Co lifted its holdings in Danaher by 75.4% during the second quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock worth $1,090,000 after buying an additional 1,874 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Analyst Ratings Changes
A number of research firms recently weighed in on DHR. Stifel Nicolaus increased their price objective on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Monday, November 18th. Raymond James cut their price target on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. UBS Group lowered their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Finally, Royal Bank of Canada dropped their target price on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.
Danaher Trading Up 0.8 %
DHR opened at $237.65 on Tuesday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a 1-year low of $215.68 and a 1-year high of $281.70. The company has a fifty day moving average price of $257.38 and a two-hundred day moving average price of $259.93. The company has a market cap of $171.65 billion, a P/E ratio of 45.35, a price-to-earnings-growth ratio of 4.34 and a beta of 0.85.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the previous year, the company earned $2.02 earnings per share. Danaher’s revenue for the quarter was up 3.1% on a year-over-year basis. Analysts predict that Danaher Co. will post 7.5 EPS for the current fiscal year.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is currently 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
- Five stocks we like better than Danaher
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Is Seaboard Corporation a Thanksgiving Feast for Investors?
- What is a support level?
- Gold’s Post-Election Moves: Key Investment Opportunities
- Pros And Cons Of Monthly Dividend Stocks
- Bath & Body Works Stock Jumps 17%: Is More Growth Ahead?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.